Airport chair delays vote on medical project, cites Hogsett concerns
Airport authority board Chairman Kelly Flynn sent an email Tuesday evening to other board members, telling them “we need to take a step back” on Athlete’s Business Network’s plan.
Health Care Businesses
Articles
UPDATE: Lilly shares fall after it changes goal for Alzheimer’s trial
Shares in Eli Lilly and Co. fell Tuesday on concerns surrounding the potential approval of a drug designed to treat dementia caused by Alzheimer's disease.
Premier Healthcare warns of data breach after theft
The company announced Monday that a missing laptop contains the names, addresses, Social Security numbers and other confidential information of more than 200,000 patients.
A new partnership rings up big savings for Anthem, Franciscan
Under the deal, Franciscan was financially accountable for what it would spend on care for about 60,000 patients who had Anthem benefits provided by its employers or purchased individually. Would it work?
Indy firm nabs $15M to expand brain surgery technologies
The new funding builds on the $18 million NICO Corp. has raised from investors since its founding in 2008. The money will help the firm conduct clinical trials, commercialize new products and expand its staff beyond North America.
New life sciences research institute lands $100M donation
The Indiana Biosciences Research Institute, set up just three years ago, announced Wednesday morning that it has been awarded grants of $80 million from the Lilly Endowment and $20 million from the Eli Lilly and Co. Foundation.
CEO behind $500M airport proposal has mixed track record
The top executive at an Indianapolis start-up that wants to build a $500 million medical complex at the Indianapolis International Airport launched a 200-location Dunkin' Donuts business that went bankrupt in 2009 and he filed for personal bankruptcy in 2013.
St. Vincent joins short list of top trauma centers in state
The trauma center at St. Vincent Indianapolis has become the third such facility in the state to be recognized as a Level I Trauma Center, meaning it is equipped and staffed to handle the most serious injuries.
Teva closing in on $40B buy of Allergan generics unit
Teva’s acquisition will make it the world’s largest maker of generic medicines, giving it greater negotiating power with governments and private-health insurers.
Cook Medical issues fourth recall in 18 months
The Bloomington company’s latest recall comes as the company is dealing with a deluge of product lawsuits.
UPDATE: Nightingale CEO claims state retaliated for report of ‘racially tinged’ remarks
The home-health firm’s lawsuit alleges state officials discriminated against the company and CEO Dev Brar when they conducted inspections that led Medicare to terminate payments to the company.
Carmel-based Stratice aims to be Amazon of health care
Carmel-based Stratice Healthcare LLC wants to take the concept of electronic prescribing for drugs and extend it to most of the rest of the health care system.
Firm aims to nationally distribute brain care innovation
Preferred Population Health Management is trying to get hospital systems, health insurers and area agencies on aging to use a set of tools and techniques to help dementia patients and their families—tools that were developed by the medical staff at Eskenazi Health, the Indiana University School of Medicine and the Regenstrief Institute.
Lilly’s 2016 sales, profit guidance falls short of predictions
Indianapolis-based Eli Lilly and Co., which has promised to return to growth after a half-decade of falling revenue, indicated that 2016 earnings might be below analysts’ estimates.
First-of-a-kind drug approvals continued rise in 2015
The rising figures reflect an industry-wide focus on drugs for rare and hard-to-treat diseases, which often come with streamlined reviews, extra patent protections and higher price tags.
IU Health shuffles execs in advance of Evans’ retirement
The state’s largest hospital system will promote IU Health Arnett President Al Gatmaitin president to chief operating officer, replacing Dennis Murphy, who is set to become CEO in April.
FDA OKs once-a-day insulin that could be blockbuster for Lilly
The FDA said Wednesday it approved Basaglar based on data showing it is safe and effective and works similarly to Lantus, the world’s top-selling insulin.
Startup for therapeutic gear raises $3M on way to market
Fishers-based Recovery Force LLC, which develops high-tech compression wearables for medical patients, athletes and military members, is working toward FDA approval.
Lilly separating manufacturing of animal health drugs
Eli Lilly and Co. is in the process of separating the manufacturing of its animal health drugs from the facilities used to make its traditional pharmaceuticals, a move that potentially could make it easier to spin off the division one day.
Pfizer-Allergan $160B deal forms world’s largest drugmaker
It's also the largest so-called inversion, where an American corporation combines with a company headquartered in a country with a lower corporate tax rate, saving potentially millions each year in U.S. taxes.